Clinical and Diagnostical Values of Plasma α-Synuclein and Melatonin Levels in Early Stages of Parkinson’s Disease
| dc.contributor.author | Biriuk, V. | |
| dc.contributor.author | Demchenko, A. V. | |
| dc.contributor.author | Gorbachova, S. | |
| dc.contributor.author | Горбачова, Світлана Василівна | |
| dc.date.accessioned | 2021-05-13T06:40:24Z | |
| dc.date.available | 2021-05-13T06:40:24Z | |
| dc.date.issued | 2020 | |
| dc.description.abstract | Parkinson’s disease (PD) is a widespread, progressive neurodegenerative disorder with complex pathogenesis. The combination of its motor and non-motor symptoms significantly impairs a patient’s life quality. The question of targeted patogenetic therapy of Parkinson’s disease is still relevant, which is why biomarkers for early diagnosis and neuroprotective therapy are urgently required. | uk_UK |
| dc.identifier.citation | Clinical and Diagnostical Values of Plasma α-Synuclein and Melatonin Levels in Early Stages of Parkinson’s Disease / V. Biriuk, A. V. Demchenko, S. Gorbachova // Biological Markers and Guided Therapy. - 2020. - Vol. 7, № 1. – P. 51-60. - https://doi.org/10.12988/bmgt.2020.91020 | uk_UK |
| dc.identifier.uri | https://zsmu.rosbai.com/handle/123456789/13631 | |
| dc.language.iso | en | uk_UK |
| dc.subject | Parkinson’s disease | uk_UK |
| dc.subject | early stages | uk_UK |
| dc.subject | α-synuclein | uk_UK |
| dc.subject | melatonin | uk_UK |
| dc.subject | cognitive impairment | uk_UK |
| dc.subject | sleep disorders | uk_UK |
| dc.title | Clinical and Diagnostical Values of Plasma α-Synuclein and Melatonin Levels in Early Stages of Parkinson’s Disease | uk_UK |
| dc.type | Article | uk_UK |